Company Overview of Alinea Pharmaceuticals, Inc.
Alinea Pharmaceuticals, Inc. develops and commercializes biopharmaceutical therapeutic products for the treatment of diabetes and related metabolic disorders. The company’s products include Aldose Reductase Inhibitors, a rate controlling enzyme in the polyol pathway of glucose metabolism whereby excess glucose is converted into fructose and sorbitol in tissues, such as the retina, kidney, and nerves. It also offers Phosphotyrosine Phosphatase, which involves in insulin and leptin signaling and a mechanism for down-regulating the insulin and leptin receptor signaling pathways. Alinea Pharmaceuticals, Inc. was founded in 2005 and is based in Cambridge, Massachusetts.
One Memorial Drive
Cambridge, MA 02142-1313
Founded in 2005
Key Executives for Alinea Pharmaceuticals, Inc.
Alinea Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|RiboNova Inc.||United States|
|NanoBioMagnetics, Inc.||United States|
|Synlogic, Inc.||United States|
|Pervasis Therapeutics, Inc.||United States|
|Mellitus, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Alinea Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.